The Effects of Selenium Supplementation on Gene Expression Related to Insulin and Lipid in Infertile Polycystic Ovary Syndrome Women Candidate for In Vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial

Biological Trace Element Research

Volumn 183, Issue 2, 2018, Pages 218-225

  Zadeh Modarres, Shahrzad ^a   Heidar, Zahra ^b   Foroozanfard, Fatemeh ^c   Rahmati, Zahra ^a   Aghadavod, Esmat ^c   Asemi, Zatollah ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gene expression; Insulin; Lipid; Polycystic ovary syndrome; Selenium supplementation

Indexed keywords

GLUCOSE TRANSPORTER 1; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SELENIUM; INSULIN; LDLR PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; IN VITRO FERTILIZATION; INFERTILITY; INSULIN LEVEL; LIPID LEVEL; LIPOPROTEIN BLOOD LEVEL; LYMPHOCYTE; MINERAL SUPPLEMENTATION; OVARY POLYCYSTIC DISEASE; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT DURATION; UPREGULATION; FEMALE INFERTILITY; LIPID METABOLISM; METABOLISM; PHYSIOLOGY;

DOUBLE-BLIND METHOD; FEMALE; FERTILIZATION IN VITRO; GLUCOSE TRANSPORTER TYPE 1; HUMANS; INFERTILITY, FEMALE; INSULIN; LIPID METABOLISM; POLYCYSTIC OVARY SYNDROME; PPAR GAMMA; RECEPTORS, LDL; SELENIUM;

EID: 85028996315     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-017-1148-2     Document Type: Article

References (50)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745–2749
2. Fulghesu AM, Villa P, Pavone V et al (1997) The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab 82:644–648
3. Dale PO, Tanbo T, Haug E, Abyholm T (1998) The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome. Hum Reprod 13:567–570
4. Uno K, Katagiri H, Yamada T et al (2006) Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 312:1656–1659
5. Puttabyatappa M, Vandevoort CA, Chaffin CL (2010) hCG-induced down-regulation of PPARgamma and liver X receptors promotes periovulatory progesterone synthesis by macaque granulosa cells. Endocrinology 151:5865–5872
6. Carlioglu A, Kaygusuz I, Karakurt F et al (2014) The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome. Arch Gynecol Obstet 290:929–935
7. Liu ML, Ylitalo K, Salonen R, Salonen JT, Taskinen MR (2004) Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families. Arterioscler Thromb Vasc Biol 24:1492–1497
8. Navarro-Alarcon M, Cabrera-Vique C (2008) Selenium in food and the human body: a review. Sci Total Environ 400:115–141
9. Jamilian M, Samimi M, Afshar Ebrahimi F et al (2017) Effects of selenium supplementation on gene expression levels of inflammatory cytokines and vascular endothelial growth factor in patients with gestational diabetes. Biol Trace Elem Res. 10.1007/s12011-017-1045-8
10. El Dib R, Gameiro OL, Ogata MS et al (2015) Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance. Cochrane database Syst rev:CD005525
11. Asemi Z, Jamilian M, Mesdaghinia E, Esmaillzadeh A (2015) Effects of selenium supplementation on glucose homeostasis, inflammation, and oxidative stress in gestational diabetes: randomized, double-blind, placebo-controlled trial. Nutrition 31:1235–1242
12. Lu J, Holmgren A (2009) Selenoproteins. J Biol Chem 284:723–727
13. Donma MM, Donma O (2016) Promising link between selenium and peroxisome proliferator activated receptor gamma in the treatment protocols of obesity as well as depression. Med Hypotheses 89:79–83
14. Gao X, Zhang Z, Li Y et al (2016) Selenium deficiency deteriorate the inflammation of S. aureus infection via regulating NF-kappaB and PPAR-gamma in mammary gland of mice. Biol Trace Elem Res 172:140–147
15. Vunta H, Davis F, Palempalli UD et al (2007) The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. J Biol Chem 282:17964–17973
16. Hussein O, Rosenblat M, Refael G, Aviram M (1997) Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients. Transplantation 63:679–685
17. Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 33:981–1030
18. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25
19. Hatch R, Rosenfield RL, Kim MH, Tredway D (1981) Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140:815–830
20. Gmelig-Meyling F, Waldmann TA (1980) Separation of human blood monocytes and lymphocytes on a continuous Percoll gradient. J Immunol Methods 33:1–9
21. Burk RF, Norsworthy BK, Hill KE, Motley AK, Byrne DW (2006) Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial. Cancer Epidemiol Biomark Prev 15:804–810
22. Aldosary BM, Sutter ME, Schwartz M, Morgan BW (2012) Case series of selenium toxicity from a nutritional supplement. Clin Toxicol (Phila) 50:57–64
23. Asemi Z, Foroozanfard F, Hashemi T, Bahmani F, Jamilian M, Esmaillzadeh A (2015) Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin Nutr 34:586–592
24. Foroozanfard F, Jamilian M, Bahmani F et al (2015) Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Clin Endocrinol 83:888–894
25. Wang YX, Zhu WJ, Xie BG (2014) Expression of PPAR-gamma in adipose tissue of rats with polycystic ovary syndrome induced by DHEA. Mol Med Rep 9:889–893
26. Akyurek N, Aycan Z, Cetinkaya S, Akyurek O, Yilmaz Agladioglu S, Ertan U (2013) Peroxisome proliferator activated receptor (PPAR)-gamma concentrations in childhood obesity. Scand J Clin Lab Invest 73:355–360
27. Mueller AS, Pallauf J (2006) Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice. J Nutr Biochem 17:548–560
28. TJ X, Liu Y, Yuan B (2011) Effect of insulin in combination with selenium on Irs/PI3K-mediated GLUT4 expression in cardiac muscle of diabetic rats. Eur Rev Med Pharmacol Sci 15:1452–1460
29. Nido SA, Shituleni SA, Mengistu BM et al (2016) Effects of selenium-enriched probiotics on lipid metabolism, antioxidative status, histopathological lesions, and related gene expression in mice fed a high-fat diet. Biol Trace Elem Res 171:399–409
30. Zhou F, Shi LB, Zhang SY (2017) Ovarian fibrosis: a phenomenon of concern. Chin Med J 130:365–371
31. Strakova N, Ehrmann J, Bartos J, Malikova J, Dolezel J, Kolar Z (2005) Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors. Neoplasma 52:126–136
32. Legro RS (2003) Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 24:302–312
33. Cassar S, Teede HJ, Harrison CL, Joham AE, Moran LJ, Stepto NK (2015) Biomarkers and insulin sensitivity in women with PCOS: characteristics and predictive capacity. Clin Endocrinol 83:50–58
34. Unfer V, Porcaro G (2014) Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. Expert Rev Clin Pharmacol 7:623–631
35. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E (2006) Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr 84:762–773
36. Brown BG, Zhao XQ, Chait A et al (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583–1592
37. Hercberg S (2006) The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health. Ann Pharm Fr 64:397–401
38. Li R, Xu X, Chen C et al (2015) CYP2J2 Attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPAR gamma. Am J Physiol Endocrinol Metab 308:E270–E282
39. Zhang W, Zhang R, Wang T et al (2014) Selenium inhibits LPS-induced pro-inflammatory gene expression by modulating MAPK and NF-kappaB signaling pathways in mouse mammary epithelial cells in primary culture. Inflammation 37:478–485
40. Gandhi UH, Kaushal N, Ravindra KC et al (2011) Selenoprotein-dependent up-regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR) gamma. J Biol Chem 286:27471–27482
41. Ghaffari T, Nouri M, Irannejad E, Rashidi MR (2011) Effect of vitamin e and selenium supplement on paraoxonase-1 activity, oxidized low density lipoprotein and antioxidant defense in diabetic rats. Bioimpacts 1:121–128
42. Leborgne L, Pakala R, Dilcher C et al (2005) Effect of antioxidants on atherosclerotic plaque formation in balloon-denuded and irradiated hypercholesterolemic rabbits. J Cardiovasc Pharmacol 46:540–547
43. Alissa EM, Ahmed WH, Al-ama N, Ferns GA (2008) Selenium status and cardiovascular risk profile in healthy adult Saudi males. Molecules 14:141–159
44. Inoue T, Uchida T, Kamishirado H, Takayanagi K, Hayashi T, Morooka S (2001) Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol 37:775–779
45. Galle J, Hansen-Hagge T, Wanner C, Seibold S (2006) Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 185:219–226
46. Kuzuya M, Nakamura K, Sasaki T, Cheng XW, Itohara S, Iguchi A (2006) Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arterioscler Thromb Vasc Biol 26:1120–1125
47. Auge N, Maupas-Schwalm F, Elbaz M et al (2004) Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 110:571–578
48. Ghaffari T, Nouri M, Saei AA, Rashidi MR (2012) Aldehyde and xanthine oxidase activities in tissues of streptozotocin-induced diabetic rats: effects of vitamin E and selenium supplementation. Biol Trace Elem Res 147:217–225
49. Ozturk IC, Batcioglu K, Karatas F, Hazneci E, Genc M (2008) Comparison of plasma malondialdehyde, glutathione, glutathione peroxidase, hydroxyproline and selenium levels in patients with vitiligo and healthy controls. Indian J Dermatol 53:106–110
50. Rohr-Udilova N, Sieghart W, Eferl R et al (2012) Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma. Hepatology 55:1112–1121